InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-15.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sailer Carl, Director. Officer active across 1 company, notably Acurx Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €268k. Activity tracked since 29 June 2021. The latest transaction was disclosed on 6 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
24,631 shares@ US$1.0157.3% of flowCommon StockSEC:0001104659-25-002053:0
Ideal exit: 3 Oct 2025 (T+270)
19,737 shares@ US$3.5519.4% of flowCommon StockSEC:0001104659-24-005357:0
19,737 shares@ US$3.8022.1% of flowCommon StockSEC:0001104659-22-084317:0
Ideal exit: 23 Apr 2023 (T+270)
5,161 shares@ US$4.840.38% mcap13.0% of flowCommon StockSEC:0001104659-21-143551:0
Ideal exit: 20 Aug 2022 (T+270)
5,161 shares@ US$4.846.7% of flowCommon StockSEC:0001104659-21-143551
Ideal exit: 20 Aug 2022 (T+270)
12,500 shares@ US$6.001.08% mcap37.0% of flowCommon StockSEC:0001104659-21-114674:0
Ideal exit: 26 Mar 2022 (T+270)
12,500 shares@ US$6.0018.9% of flowCommon StockSEC:0001104659-21-114674
Ideal exit: 26 Mar 2022 (T+270)
7 of 7 declarations
About Sailer Carl
Carl Sailer is a Board Member at Acurx Pharmaceuticals, Inc. He plays a key role in overseeing the company's activities and making strategic decisions. Through his experience, he contributes to developing effective governance practices and achieving growth objectives. His commitment to innovation and corporate social responsibility is a valuable asset to the board.
